(Reuters) -Bausch + Lomb said on Thursday it has acquired Johnson & Johnson’s eye and contact lens drops for $106.5 million in an all-cash deal to expand its portfolio of over-the-counter eye care products.
This comes after the company struck a $1.75 billion deal with Swiss drugmaker Novartis late last month to buy several eye-care products including anti-inflammation eye drop Xiidra.
(Reporting by Mariam Sunny in Bengaluru; Editing by Dhanya Ann Thoppil and Savio D’Souza)
